In empiric meningitis management for adults, which drug provides MRSA coverage?

Prepare for emergency medicine exams with our comprehensive test. Explore multiple choice questions, receive hints and explanations. Sharpen your knowledge and ensure success!

Multiple Choice

In empiric meningitis management for adults, which drug provides MRSA coverage?

Explanation:
MRSA coverage in adult empiric meningitis comes from vancomycin because MRSA is resistant to most beta-lactam antibiotics used for meningitis, and vancomycin remains active against MRSA. In standard empiric regimens, vancomycin is added to cover resistant staphylococci, while ceftriaxone (a third-generation cephalosporin) covers other common pathogens but not MRSA. Ampicillin targets Listeria, not MRSA. Dexamethasone is a corticosteroid used to reduce inflammation and improve outcomes in some meningitis cases, but it does not provide antimicrobial coverage. Therefore, vancomycin is the drug that provides MRSA coverage.

MRSA coverage in adult empiric meningitis comes from vancomycin because MRSA is resistant to most beta-lactam antibiotics used for meningitis, and vancomycin remains active against MRSA. In standard empiric regimens, vancomycin is added to cover resistant staphylococci, while ceftriaxone (a third-generation cephalosporin) covers other common pathogens but not MRSA. Ampicillin targets Listeria, not MRSA. Dexamethasone is a corticosteroid used to reduce inflammation and improve outcomes in some meningitis cases, but it does not provide antimicrobial coverage. Therefore, vancomycin is the drug that provides MRSA coverage.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy